Wed, February 16, 2022
Tue, February 15, 2022
Mon, February 14, 2022

Madhu Kumar Initiated (SNDX) at Strong Buy and Held Target at $37 on, Feb 15th, 2022

Madhu Kumar of Goldman Sachs, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $37 on, Feb 15th, 2022.

Madhu, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30